TrueBinding Inc. Founded in 2016, our mission is to advance therapies that have the potential to transform patient outcomes in areas such as neurodegenerative diseases, stroke, metabolic disorders, oncology, and more. At TrueBinding, we pride ourselves on our cutting-edge TrueBinding™ platform, which is a proprietary technology that has proven its worth in drug discovery and development.

With this powerful platform, we have already discovered and validated over 6 novel drug targets, making significant strides in the biopharmaceutical industry. In addition to our groundbreaking research, TrueBinding also offers contract development and manufacturing services. With our expertise and state-of-the-art facilities, we enable biopharmaceutical companies to accelerate the development and production of monoclonal antibodies efficiently.

Join us in our mission to bring hope to patients and healthcare providers alike as we continue to innovate and make a difference in the field of biopharmaceuticals